HTA and innovative treatments evaluation: the case of metastatic castration-resistant prostate cancer [Corrigendum]

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689527/
https://www.ncbi.nlm.nih.gov/pubmed/31496768
http://dx.doi.org/10.2147/CEOR.S225177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689527/
https://www.ncbi.nlm.nih.gov/pubmed/31496768
http://dx.doi.org/10.2147/CEOR.S225177

Ejemplares similares